The 2008 San Antonio Breast Cancer Symposium, December 10-14, 2008

Main Category: Breast Cancer
Also Included In: Medical Devices / Diagnostics;  Clinical Trials / Drug Trials
Article Date: 05 Nov 2008 - 4:00 PDT

email to a friend   printer friendly   view / write opinions   rate article

The CTRC-AACR San Antonio Breast Cancer Symposium features the latest findings in laboratory, translational and clinical breast cancer research. This year's meeting focuses on new and promising therapeutic approaches, as well as strides being made in diagnosing and preventing breast cancer.

The 2008 San Antonio Breast Cancer Symposium (SABCS) will be the first Symposium presented by the CTRC (Cancer Therapy & Research Center) at the University of Texas Health Science Center at San Antonio, AACR and the Baylor College of Medicine. More than 1,000 abstracts will be presented at the symposium, complementing an outstanding program of scientific and educational events.

Highlights:

• Practice-changing data on the role of zolendric acid in late-stage breast cancer
  
  
• How changes in breast density can predict outcome with tamoxifen
  
  
• Why rest is as important as physical activity in breast cancer prevention
  
  
• Recurrence rates among patients with small HER2-positive tumors
  
  
• Evaluation of letrozole as adjuvant endocrine therapy
  
  
• Phase III trials of new, paradigm-shifting clinical agents like topoisomerase

When:
December 10-14, 2008

Where:
Henry B. Gonzales Convention Center
San Antonio, TX

----------------------------
Article adapted by Medical News Today from original press release.
----------------------------

http://www.sabcs.org/

Source: Jill Byrd
American Association for Cancer Research